Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
India · Delayed Price · Currency is INR 50.00
-1.00 (-1.96%)
At close: Feb 12, 2026
NSE:AAKAAR Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 592.03 | 615.83 | 461.11 | 327.85 | 194.65 | 124.38 |
Other Revenue | 0 | - | - | - | - | - |
| 592.04 | 615.83 | 461.11 | 327.85 | 194.65 | 124.38 | |
Revenue Growth (YoY) | - | 33.55% | 40.65% | 68.42% | 56.50% | -45.88% |
Cost of Revenue | 246.63 | 262.25 | 210.07 | 150.08 | 91.04 | 63.35 |
Gross Profit | 345.4 | 353.58 | 251.04 | 177.77 | 103.61 | 61.03 |
Selling, General & Admin | 137.16 | 129.03 | 128.69 | 77.28 | 39.76 | 30.28 |
Other Operating Expenses | 127.13 | 126.88 | 71.53 | 63.44 | 39.18 | 19.17 |
Operating Expenses | 265.44 | 257.16 | 201.57 | 141.62 | 79.16 | 49.77 |
Operating Income | 79.96 | 96.42 | 49.47 | 36.15 | 24.45 | 11.26 |
Interest Expense | -18.15 | -15.77 | -9.91 | -3.61 | -0.3 | -4.22 |
Interest & Investment Income | 0.13 | 0.13 | 0.16 | 0.12 | 0.16 | 0.12 |
Currency Exchange Gain (Loss) | 1.35 | 1.35 | 0.6 | -0.8 | 0.2 | 0.72 |
Other Non Operating Income (Expenses) | 0.97 | -1.33 | -1.46 | -0.7 | 0 | -0 |
EBT Excluding Unusual Items | 64.26 | 80.81 | 38.85 | 31.17 | 24.51 | 7.88 |
Asset Writedown | - | - | - | -0.14 | - | - |
Other Unusual Items | - | - | - | - | - | -0.24 |
Pretax Income | 64.26 | 80.81 | 38.85 | 31.03 | 24.51 | 7.64 |
Income Tax Expense | 16.35 | 20.41 | 10.15 | 9.49 | 6.52 | 2.2 |
Net Income | 47.91 | 60.4 | 28.7 | 21.53 | 18 | 5.44 |
Net Income to Common | 47.91 | 60.4 | 28.7 | 21.53 | 18 | 5.44 |
Net Income Growth | - | 110.42% | 33.30% | 19.65% | 230.59% | -70.22% |
Shares Outstanding (Basic) | 11 | 10 | 9 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 11 | 10 | 9 | 9 | 9 | 9 |
Shares Change (YoY) | 22.95% | 7.84% | 0.19% | 0.26% | - | - |
EPS (Basic) | 4.19 | 6.13 | 3.15 | 2.37 | 1.98 | 0.60 |
EPS (Diluted) | 4.19 | 6.13 | 3.14 | 2.36 | 1.98 | 0.60 |
EPS Growth | - | 95.12% | 33.05% | 19.34% | 230.59% | -70.22% |
Free Cash Flow | - | -54.9 | -80.96 | -31.91 | 1.11 | 42.97 |
Free Cash Flow Per Share | - | -5.57 | -8.86 | -3.50 | 0.12 | 4.72 |
Dividend Per Share | - | - | - | 0.577 | 0.615 | - |
Dividend Growth | - | - | - | -6.26% | - | - |
Gross Margin | 58.34% | 57.42% | 54.44% | 54.22% | 53.23% | 49.07% |
Operating Margin | 13.51% | 15.66% | 10.73% | 11.03% | 12.56% | 9.06% |
Profit Margin | 8.09% | 9.81% | 6.22% | 6.57% | 9.25% | 4.38% |
Free Cash Flow Margin | - | -8.91% | -17.56% | -9.73% | 0.57% | 34.55% |
EBITDA | 81.02 | 97.67 | 50.82 | 37.05 | 24.67 | 11.59 |
EBITDA Margin | 13.69% | 15.86% | 11.02% | 11.30% | 12.67% | 9.31% |
D&A For EBITDA | 1.06 | 1.25 | 1.35 | 0.89 | 0.22 | 0.32 |
EBIT | 79.96 | 96.42 | 49.47 | 36.15 | 24.45 | 11.26 |
EBIT Margin | 13.51% | 15.66% | 10.73% | 11.03% | 12.56% | 9.06% |
Effective Tax Rate | 25.45% | 25.26% | 26.13% | 30.60% | 26.59% | 28.77% |
Revenue as Reported | 596.11 | 617.61 | 462.7 | 328.79 | 195.09 | 124.9 |
Advertising Expenses | - | 28.89 | 21.28 | 17.41 | - | 0.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.